Conflicts of interest bedevil psychiatric drug research

Does it matter if most of the experts who are creating definitions of mental disorders, and standards for the best way to treat them, receive money from pharmaceutical companies? Critics such as Cosgrove say there’s a damaging conflict of interest in the financial ties between drug companies and leaders who are revising the “bible” of psychiatric diagnoses, the Diagnostic and Statistical Manual of Mental Disorders (DSM-V), as well as guidelines on the best treatments.

more